Phase 3 Type 2 Diabetes Trial, Not Yet Recruiting NCT07613307 Sponsor: Eli Lilly and Company Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Phase 3 Type 2 Diabetes Trial, Not Yet Recruiting

NCT07613307
Not Yet Recruiting Phase 3

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been clinically diagnosed with type 2 diabetes, based on World Health Organization standards or other relevant local guidelines.
  • People whose HbA1c (a measure of average blood sugar levels over time) was between 7.0% and less than 9.5% at the screening appointment.
  • People who plan to fast during the Ramadan period as required by the trial.
  • People whose body weight has been stable, with a self-reported change of 5 kilograms or less in the 90 days before screening.
  • People with a body mass index (BMI, a measure of body weight relative to height) of 25 or higher at screening.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have any form of diabetes other than type 2 diabetes, including type 1 diabetes, gestational diabetes, latent autoimmune diabetes, maturity-onset diabetes of the young, or diabetes caused by medication.
  • People who have a personal history, or a close family member (parent, sibling, or child) with a history, of a specific type of thyroid cancer (medullary thyroid carcinoma) or a condition called multiple endocrine neoplasia syndrome type 2.
  • People who have ever had chronic or acute pancreatitis (inflammation of the pancreas) at any point before screening.
  • People who, in the opinion of the trial investigator, have a significant uncontrolled hormonal condition, such as a thyroid or adrenal crisis.
  • People who have had an active or untreated cancer, or who have been in remission from a significant cancer for less than 5 years.
  • People who have had their gallbladder surgically removed.
  • People who have been classified as having the most severe level (Class IV) of heart failure according to a standard medical rating scale.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026

Contact this trial

Principal Investigator: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company

Phone: 1-317-615-4559

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 3
Registry
ClinicalTrials.gov
Start date
1 July 2026
Est. completion
1 May 2027

Where this trial is recruiting

🇮🇳 India 🇸🇦 Saudi Arabia 🇿🇦 South Africa 🇦🇪 United Arab Emirates

Primary endpoints

Change from Baseline in Hemoglobin A1C (HbA1c)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov